Biocon's subsidiary receives GMP compliance certificate from MHRA, UK

On Sensex, Biocon closed at Rs404.10 per piece down by 3.85%.

Apr 12, 2021 05:04 IST India Infoline News Service

Biocon
Biocon on Monday said that the wholly-owned subsidiary, Biocon Pharma has received a GMP compliance certificate from MHRA, UK.

Biocon said, "This is to inform you that Biocon Pharma Limited, a wholly-owned subsidiary of Biocon Limited, has received a certificate of Good Manufacturing Practice (GMP) compliance from the Medicines & Healthcare products Regulatory Agency (MHRA), the United Kingdom (UK), for its manufacturing facility at Biocon Park in Bengaluru."

"The certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection in the week of 22nd March 2021, in the wake of travel restrictions amidst Covid-19," Biocon added.

On Sensex, Biocon closed at Rs404.10 per piece down by 3.85%.

Related Story

Open Free Demat Account (Rs699)